AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bijoyesh Mookerjee, MD
AstraZeneca
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Fitzroy, Australia
- Research Site
Parkville, Australia
- Research Site
Perth, Australia
- Research Site
Waratah, Australia
- Research Site
Belo Horizonte, Brazil
- Research Site
Curitiba, Brazil
- Research Site
Fortaleza, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Santro Andre, Brazil
- Research Site
São Paulo, Brazil
- Research Site
Burbank, California, United States
- Research Site
Los Angeles, California, United States
- Research Site
Palm Springs, California, United States
- Research Site
Boca Raton, Florida, United States
- Research Site
Honolulu, Hawaii, United States
- Research Site
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2007
- Primary completion
- 31 Dec 2008
- Completion
- 30 Apr 2016
- Last update posted
- 3 Aug 2016
- Registered enrollment
- 75
- Registry id
- NCT00454805
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.